This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fellinger, E. J. Articles by Rettig, W. J. Search for Related Content PubMed PubMed Citation Articles by Fellinger, E. J. Articles by Rettig, W. J.

American Journal of Pathology, Vol 139, 317-325, Copyright © 1991 by American Society for Investigative Pathology

REGULAR ARTICLES

Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32MIC2

EJ Fellinger, P Garin-Chesa, TJ Triche, AG Huvos and WJ Rettig
Department of Immunology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

Monoclonal antibody (MAb) HBA71, which was raised against Ewing's sarcoma cells, recognizes a cell-surface glycoprotein, p30/32MIC2, that is encoded by the MIC2 gene in the pseudoautosomal region of human chromosomes X and Y. This immunohistochemical study evaluates the specificity and sensitivity of MAb HBA71 for tumor diagnosis. Frozen and paraffin-embedded tissues of more than 300 tumors of diverse histologic type, including more than 100 small round cell tumors of childhood and adolescence, were tested with this MAb by the avidin- biotin immunoperoxidase procedure. The authors found HBA71 immunoreactivity in 61 of 63 Ewing's sarcomas studied and 9 of 11 primitive neuroectodermal tumors and peripheral neuroepitheliomas. HBA71-negative tumors included neuroblastomas (0 of 24), melanomas (0 of 13), an esthesioneuroblastoma, small cell osteosarcomas (0 of 2), a malignant ectomesenchymoma, desmoplastic SRCT (0 of 5), and medulloblastomas (0 of 5). Heterogeneous expression of HBA71 immunostaining was found in some embryonal rhabdomyosarcomas (3 of 14) and astrocytomas (4 of 7), and in a few neuroendocrine tumors (4 of 26), carcinomas (3 of 94), and lymphomas (6 of 30). Because Ewing's sarcomas are consistently HBA71 positive, the authors searched for antigen-positive normal cells that may represent precursors for these tumors; however, no obvious candidate for the elusive cell of origin for Ewing's sarcoma was identified in the normal fetal tissues tested. Their findings indicate that HBA71 is a highly restricted cell-surface antigen of Ewing's sarcomas and primitive neuroectodermal tumors, and immunohistochemistry employing this antibody may be of value in the differential diagnosis of selected small round cell tumors in childhood and adolescence.

This article has been cited by other articles:

				T. M. Zagar, T. J. Triche, and T. J. Kinsella Extraosseous Ewing's Sarcoma: 25 Years Later J. Clin. Oncol., September 10, 2008; 26(26): 4230 - 4232. [Full Text] [PDF]

				A. Kuzucu, H. S. Erkal, O. Soysal, and M. Serin Extraskeletal Ewing's Sarcoma Presenting With Multifocal Intrathoracic Mass Lesions Associated With Mediastinal Shift Ann. Thorac. Surg., April 1, 2006; 81(4): 1487 - 1488. [Abstract] [Full Text] [PDF]

				J.S. Pekala, S. Gururangan, J.M. Provenzale, and S. Mukundan Jr. Central Nervous System Extraosseous Ewing Sarcoma: Radiologic Manifestations of This Newly Defined Pathologic Entity AJNR Am. J. Neuroradiol., March 1, 2006; 27(3): 580 - 583. [Abstract] [Full Text] [PDF]

				M. R. Verneris, A. Arshi, M. Edinger, M. Kornacker, Y. Natkunam, M. Karami, Y.-a. Cao, N. Marina, C. H. Contag, and R. S. Negrin Low Levels of Her2/neu Expressed by Ewing's Family Tumor Cell Lines Can Redirect Cytokine-Induced Killer Cells Clin. Cancer Res., June 15, 2005; 11(12): 4561 - 4570. [Abstract] [Full Text] [PDF]

				E. A. Kolb, B. H. Kushner, R. Gorlick, C. Laverdiere, J. H. Healey, M. P. LaQuaglia, A. G. Huvos, J. Qin, H. T. Vu, L. Wexler, et al. Long-Term Event-Free Survival After Intensive Chemotherapy for Ewing's Family of Tumors in Children and Young Adults J. Clin. Oncol., September 15, 2003; 21(18): 3423 - 3430. [Abstract] [Full Text] [PDF]

				S. Geaghan Pathological Case of the Month Arch Pediatr Adolesc Med, March 1, 2001; 155(3): 409 - 410. [Full Text] [PDF]

				L. Landuzzi, C. De Giovanni, G. Nicoletti, I. Rossi, C. Ricci, A. Astolfi, L. Scopece, K. Scotlandi, M. Serra, G. P. Bagnara, et al. The Metastatic Ability of Ewing's Sarcoma Cells Is Modulated by Stem Cell Factor and by Its Receptor c-kit Am. J. Pathol., December 1, 2000; 157(6): 2123 - 2131. [Abstract] [Full Text] [PDF]

				W. L. Gerald A Practical Approach to the Differential Diagnosis of Small Round Cell Tumors of Infancy Using Recent Scientific and Technical Advances International Journal of Surgical Pathology, April 1, 2000; 8(2): 87 - 97. [Abstract] [PDF]

				A. Llombart-Bosch Ewing's Sarcoma and Peripheral Primitive Neuroectodermal Tumor of Bone and Soft Tissue: A Review International Journal of Surgical Pathology, October 1, 1999; 7(4): 185 - 192. [Abstract] [PDF]

				H. W. Sohn, E. Y. Choi, S. H. Kim, I.-s. Lee, D. H. Chung, U. A Sung, D. H. Hwang, S. S. Cho, B. H. Jun, J. J. Jang, et al. Engagement of CD99 Induces Apoptosis Through a Calcineurin-Independent Pathway in Ewing's Sarcoma Cells Am. J. Pathol., December 1, 1998; 153(6): 1937 - 1945. [Abstract] [Full Text] [PDF]

				J. S. WUNDER, G. PAULIAN, A. G. HUVOS, G. HELLER, P. A. MEYERS, and J. H. HEALEY The Histological Response to Chemotherapy as a Predictor of the Oncological Outcome of Operative Treatment of Ewing Sarcoma J. Bone Joint Surg. Am., July 1, 1998; 80(7): 1020 - 33. [Abstract] [Full Text]

				O. Delattre, J. Zucman, T. Melot, X. S. Garau, J.-M. Zucker, G. M. Lenoir, P. F. Ambros, D. Sheer, C. Turc-Carel, T. J. Triche, et al. The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts N. Engl. J. Med., August 4, 1994; 331(5): 294 - 299. [Abstract] [Full Text]